---
title: "Esperion directors Justin Bateman and Ankit Pareek elected as six incumbent directors depart"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292494692.md"
description: "Esperion Therapeutics has elected Justin Bateman and Ankit Pareek to its board of directors following the consummation of a merger. Consequently, six incumbent directors—J. Martin Carroll, Sheldon L. Koenig, Robert E. Hoffman, Craig Thompson, Jay P. Shepard, and Seth H.Z. Fischer—ceased their roles in accordance with the Merger Agreement."
datetime: "2026-07-13T13:13:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292494692.md)
  - [en](https://longbridge.com/en/news/292494692.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292494692.md)
generator: "portal-rs"
---

# Esperion directors Justin Bateman and Ankit Pareek elected as six incumbent directors depart

**Esperion elected Justin Bateman and Ankit Pareek to its board upon consummation of the Merger, with six incumbent directors ceasing to serve.**

**Individual**

J. Martin Carroll

Sheldon L. Koenig

Robert E. Hoffman

Craig Thompson

Jay P. Shepard

Seth H.Z. Fischer

Justin Bateman

Ankit Pareek

**Role**

Director

Director

Director

Director

Director

Director

Director

Director

**Type of Change**

Ceased to be director

Ceased to be director

Ceased to be director

Ceased to be director

Ceased to be director

Ceased to be director

Elected

Elected

**Effective Date**

Upon consummation of the Merger

Upon consummation of the Merger

Upon consummation of the Merger

Upon consummation of the Merger

Upon consummation of the Merger

Upon consummation of the Merger

Upon consummation of the Merger

Upon consummation of the Merger

**Reason**

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

Merger; in accordance with Merger Agreement

**Replacement Info**

Justin Bateman and Ankit Pareek elected to the board

Justin Bateman and Ankit Pareek elected to the board

Justin Bateman and Ankit Pareek elected to the board

Justin Bateman and Ankit Pareek elected to the board

Justin Bateman and Ankit Pareek elected to the board

Justin Bateman and Ankit Pareek elected to the board

N/A

N/A

**Background Details**

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Director of MergerCo prior to Effective Time

Director of MergerCo prior to Effective Time

**Board/Committee Role Changes**

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Not disclosed

Original SEC Filing: Esperion Therapeutics, Inc. \[ ESPR \] - 8-K - Jul. 13, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ESPR.US](https://longbridge.com/en/quote/ESPR.US.md)

## Related News & Research

- [Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk](https://longbridge.com/en/news/285830726.md)
- [Esperion acquired in cash-and-CVR merger transaction](https://longbridge.com/en/news/292521304.md)
- [Esperion stockholders approve merger agreement at special meeting](https://longbridge.com/en/news/292068833.md)
- [Archimed completes take-private of Esperion in deal valued up to $1.1 billion](https://longbridge.com/en/news/292496629.md)
- [Top Esperion Executives Quietly Unload a Wave of Shares](https://longbridge.com/en/news/290261607.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**